HomeClonidineClonidine + Metoprolol Succinate Er

Does Clonidine Interact with Metoprolol Succinate Er?

Clonidine and Metoprolol Succinate Er have a major drug interaction according to U.S. FDA drug labeling data. Concomitant use increases bradycardia risk. Withdraw beta-blocker several days before clonidine withdrawal to avoid rebound hypertension exacerbation. The mechanism involves additive atrioventricular conduction slowing; beta-blockers exacerbate clonidine withdrawal rebound hypertension. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Clonidine Class
Central alpha-2 Adrenergic Agonist
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Clonidine and Metoprolol Succinate Er occurs because additive atrioventricular conduction slowing; beta-blockers exacerbate clonidine withdrawal rebound hypertension. Clinically, this means concomitant use increases bradycardia risk. withdraw beta-blocker several days before clonidine withdrawal to avoid rebound hypertension exacerbation. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Clonidine and your doctor is considering prescribing Metoprolol Succinate Er (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Clonidine(Kapvay)+💊 Metoprolol Succinate Er(Kapspargo)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Central alpha-2 Adrenergic Agonist
Drug B class
Source
NLP:metoprolol succinate er

What this means in plain English

Concomitant use increases bradycardia risk. Withdraw beta-blocker several days before clonidine withdrawal to avoid rebound hypertension exacerbation.

About Clonidine and Metoprolol Succinate Er

Clonidine is a Central alpha-2 Adrenergic Agonist. You may recognize them by the brand names Kapvay and Kapspargo. Both medications are taken by mouth. Clonidine additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"Additive atrioventricular conduction slowing; beta-blockers exacerbate clonidine withdrawal rebound hypertension"

📖 Source: NLP:metoprolol succinate er

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Clonidine and Metoprolol Succinate Er against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.